Sexual dissatisfaction in postmenopausal women not linked to cardiovascular diseaseApril 03, 2008Although sexual dysfunction in some men is predictive of cardiovascular disease, this association has never been examined in women. In an article published in the April 2008 issue of The American Journal of Medicine, researchers found no increased prevalence or incidence of cardiovascular disease among postmenopausal sexually active female subjects who were dissatisfied with their sexual activity. Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) and collaborators nationwide examined data from over 93,000 women in the Women's Health Initiative Observational Study. Participants were sexually active postmenopausal women aged 50 to 79 years, recruited at 40 clinical centers throughout the United States and followed for 8-12 years. Based on responses to a baseline survey, subjects were classified as sexually satisfied or dissatisfied. Researchers identified cardiovascular disease as a self-reported history of acute myocardial infarction, stroke, or coronary revascularization procedure. Related cardiovascular problems, including congestive heart failure, peripheral arterial disease and angina were also examined. According to researchers, there was a modest association between being dissatisfied with sexual activity and having peripheral arterial disease, and angina was decreased among those dissatisfied with sexual activity. However, there was no association between sexual dissatisfaction and the presence of any other form of cardiovascular disease including heart attack or stroke. Writing in the article, Jennifer McCall-Hosenfeld, MD, MSc, a fellow in the Department of General Internal Medicine at BMC and Women's Health at BUSM, states, "In men, erectile dysfunction is a manifestation of cardiovascular disease, and can predict the development of adverse cardiovascular outcomes such as heart attack. In our study, we used decreased sexual satisfaction as a rough proxy measure for sexual dysfunction, and controlled for lifestyle issues and other factors that might impact sexual satisfaction. We did not find that sexual satisfaction predicted cardiovascular disease in the future." Elsevier Health Sciences |
|||||||||||||||||||||
| Related Postmenopausal Current Events and Postmenopausal News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Mayo researchers find robotic repair for vaginal prolapse has significant benefits New Mayo Clinic research has found that robotic surgery for vaginal prolapse dramatically reduces patient hospital stay and recovery time. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Postmenopausal women with higher testosterone levels Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels. Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women. Novel, soy-based SE5-OH containing Natural S-equol supplement reduced hot flash frequency by nearly 59 percent SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women. Researchers believe hormone therapy should not be stopped prior to mammograms Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance The largest study in the world of treatments for post menopausal, hormone positive breast cancer has shown that patients who continue to take exemestane or tamoxifen do significantly better than patients who start to take one or other drug (or tamoxifen followed exemestane) but then stop. Postmenopausal women benefit from endurance training as much as younger women Marilyn Graham was 56 when she signed up for a grueling hour of cycling each morning for 12 weeks, occasionally decked out in a mask, a heart monitor and a bag of intravenous fluid and subjected to needle pricks to obtain blood samples. Seizure drug enhances sleep for women with hot flashes Gabapentin, a drug initially used to treat seizures, improves sleep quality in menopausal women with hot flashes, University of Rochester Medical Center researchers report online and in the September issue of the Journal of Women's Health. More Postmenopausal Current Events and Postmenopausal News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||